Marcia Angell, former editor-in-chief of the New England Journal of Medicine, thinks the influence of pharmaceutical companies has grown too large in our academic institutions. “The boundaries between academic medicine—medical schools, teaching hospitals, and their faculty—and the pharmaceutical industry have been dissolving since the 1980s, and the important differences between their missions are becoming blurred. Medical research, education, and clinical practice have suffered as a result.”